JP2003532677A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003532677A5 JP2003532677A5 JP2001581824A JP2001581824A JP2003532677A5 JP 2003532677 A5 JP2003532677 A5 JP 2003532677A5 JP 2001581824 A JP2001581824 A JP 2001581824A JP 2001581824 A JP2001581824 A JP 2001581824A JP 2003532677 A5 JP2003532677 A5 JP 2003532677A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbons
- optionally substituted
- compound
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20194300P | 2000-05-05 | 2000-05-05 | |
| US60/201,943 | 2000-05-05 | ||
| US23808400P | 2000-10-04 | 2000-10-04 | |
| US60/238,084 | 2000-10-04 | ||
| PCT/US2001/014593 WO2001085170A1 (en) | 2000-05-05 | 2001-05-04 | Peptide deformylase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003532677A JP2003532677A (ja) | 2003-11-05 |
| JP2003532677A5 true JP2003532677A5 (enExample) | 2008-06-19 |
Family
ID=26897227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001581824A Pending JP2003532677A (ja) | 2000-05-05 | 2001-05-04 | ペプチドデホルミラーゼ阻害物質 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6806369B2 (enExample) |
| EP (1) | EP1283711B1 (enExample) |
| JP (1) | JP2003532677A (enExample) |
| KR (1) | KR20020093127A (enExample) |
| CN (1) | CN1427721A (enExample) |
| AR (1) | AR029916A1 (enExample) |
| AT (1) | ATE389403T1 (enExample) |
| AU (1) | AU2001261218A1 (enExample) |
| BR (1) | BR0110206A (enExample) |
| CA (1) | CA2408236A1 (enExample) |
| CZ (1) | CZ20023618A3 (enExample) |
| DE (1) | DE60133273T2 (enExample) |
| ES (1) | ES2300330T3 (enExample) |
| HU (1) | HUP0302505A2 (enExample) |
| IL (1) | IL152638A0 (enExample) |
| MX (1) | MXPA02010843A (enExample) |
| NO (1) | NO20025281L (enExample) |
| NZ (1) | NZ521560A (enExample) |
| PL (1) | PL359865A1 (enExample) |
| WO (1) | WO2001085170A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003002522A1 (en) * | 2001-04-05 | 2003-01-09 | Smithkline Beecham Corp | Peptide deformylase inhibitors |
| ES2374664T3 (es) * | 2001-06-05 | 2012-02-20 | Glaxosmithkline Llc | Inhibidores de péptido desformilasa. |
| ES2390767T3 (es) * | 2002-12-11 | 2012-11-16 | Glaxosmithkline Llc | Inhibidores de la péptido desformilasa |
| EP1683521A1 (en) * | 2005-01-21 | 2006-07-26 | Centre National De La Recherche Scientifique (Cnrs) | Peptide deformylase inhibitors, their use, and pharmaceutical compositions containing the same |
| EP1877407A1 (en) * | 2005-04-25 | 2008-01-16 | Novartis AG | Imidazo(1,2-a)pyridine derivatives useful as peptide deformylase (pdf) inhibitors |
| DE102005019181A1 (de) | 2005-04-25 | 2006-10-26 | Novartis Ag | Peptid-Deformylase (PDF) Inhibitoren 1 |
| US7705037B2 (en) * | 2005-06-07 | 2010-04-27 | Novartis Ag | 1-substituted pyrrolidin-2-ones and use thereof as peptide deformylase inhibitors |
| WO2007040289A1 (en) * | 2005-10-05 | 2007-04-12 | Promeditech Inc. | Deformylase inhibitor, process for the preparation thereof, and composition comprising the same |
| KR100753796B1 (ko) * | 2006-07-28 | 2007-08-31 | 주식회사 프로메디텍 | 데포르밀라제 저해제, 이의 제조방법, 및 이를 포함하는조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3282986A (en) * | 1960-10-06 | 1966-11-01 | Merck & Co Inc | N-acylated hydroxamic acids and derivatives thereof |
| HU201300B (en) | 1985-03-16 | 1990-10-28 | Wellcome Found | Process for production of derivatives of aryl and medical compositions containing them as active substance |
| GB8531838D0 (en) * | 1985-12-30 | 1986-02-05 | Wellcome Found | Aryl derivatives |
| PL154186B1 (en) | 1987-07-15 | 1991-07-31 | Wellcome Found | Method for manufacturing arylic derivatives of the hydroxamic acid |
| NZ501166A (en) | 1997-07-31 | 2001-12-21 | Abbott Lab | Reverse hydroxamate-containing compounds and their use as inhibitors of matrix metalloproteinases |
| US6294573B1 (en) | 1997-08-06 | 2001-09-25 | Abbott Laboratories | Reverse hydroxamate inhibitors of matrix metalloproteinases |
| US6235786B1 (en) | 1997-08-06 | 2001-05-22 | Abbott Laboratories | Reverse hydroxamate inhibitors of matrix metalloproteinases |
| EP1052984B1 (en) | 1998-02-07 | 2004-05-12 | Vernalis (Oxford) Ltd | Antibacterial agents |
| AR028075A1 (es) * | 2000-05-05 | 2003-04-23 | Smithkline Beecham Corp | Inhibidores de la peptido-desformilasa |
| US20040034024A1 (en) | 2001-05-04 | 2004-02-19 | Aubart Kelly M | Peptide deformylase inhibitors |
-
2001
- 2001-05-03 AR ARP010102092A patent/AR029916A1/es not_active Application Discontinuation
- 2001-05-04 ES ES01935094T patent/ES2300330T3/es not_active Expired - Lifetime
- 2001-05-04 JP JP2001581824A patent/JP2003532677A/ja active Pending
- 2001-05-04 WO PCT/US2001/014593 patent/WO2001085170A1/en not_active Ceased
- 2001-05-04 CN CN01808997A patent/CN1427721A/zh active Pending
- 2001-05-04 NZ NZ521560A patent/NZ521560A/en unknown
- 2001-05-04 CZ CZ20023618A patent/CZ20023618A3/cs unknown
- 2001-05-04 PL PL35986501A patent/PL359865A1/xx unknown
- 2001-05-04 KR KR1020027014802A patent/KR20020093127A/ko not_active Withdrawn
- 2001-05-04 IL IL15263801A patent/IL152638A0/xx unknown
- 2001-05-04 AT AT01935094T patent/ATE389403T1/de not_active IP Right Cessation
- 2001-05-04 DE DE60133273T patent/DE60133273T2/de not_active Expired - Lifetime
- 2001-05-04 CA CA002408236A patent/CA2408236A1/en not_active Abandoned
- 2001-05-04 AU AU2001261218A patent/AU2001261218A1/en not_active Abandoned
- 2001-05-04 EP EP01935094A patent/EP1283711B1/en not_active Expired - Lifetime
- 2001-05-04 HU HU0302505A patent/HUP0302505A2/hu unknown
- 2001-05-04 BR BR0110206-0A patent/BR0110206A/pt not_active Application Discontinuation
- 2001-05-04 MX MXPA02010843A patent/MXPA02010843A/es unknown
- 2001-05-04 US US10/275,522 patent/US6806369B2/en not_active Expired - Fee Related
-
2002
- 2002-11-04 NO NO20025281A patent/NO20025281L/no not_active Application Discontinuation
-
2004
- 2004-04-05 US US10/818,074 patent/US7115605B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002332234A5 (enExample) | ||
| JP2005508905A5 (enExample) | ||
| JP2003531118A5 (enExample) | ||
| JP2007505916A5 (enExample) | ||
| JP2007508359A5 (enExample) | ||
| JP2005539088A5 (enExample) | ||
| JP2005053931A5 (enExample) | ||
| JP2005523922A5 (enExample) | ||
| JP2002543183A5 (enExample) | ||
| JP2002541233A5 (enExample) | ||
| JP2004532209A5 (enExample) | ||
| JP2003267957A5 (enExample) | ||
| WO2005046589A3 (en) | Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties | |
| JP2005511547A5 (enExample) | ||
| WO2005037781A3 (fr) | Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
| JP2002508362A5 (ja) | １−置換−１−アミノメチル−シクロアルカン誘導体（＝ガバペンチン類縁体） | |
| JP2003506465A5 (enExample) | ||
| ZA200704236B (en) | An oral preparation having improved bioavailability | |
| JP2010504286A5 (enExample) | ||
| JP2005538089A5 (enExample) | ||
| JP2002535387A5 (enExample) | ||
| JP2003532677A5 (enExample) | ||
| JP2005525392A5 (enExample) | ||
| JP2008546770A5 (enExample) | ||
| JP2008511597A5 (enExample) |